Intas Of India Signs Generics Deal With U.K.'s AstraZeneca For Cancer Drugs
This article was originally published in PharmAsia News
India's Intas Pharmaceutical and AstraZeneca of the United Kingdom have signed a deal for supply of generic drugs to treat cancer
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.